Home 2016

Archives

radiation dermatitis

Understanding radiation dermatitis

According to the National Cancer Institute, an estimated 1.6 million new cases of cancer will have been diagnosed in the United States in 2015....
parent

From our readers: When your parent is the patient

It’s not easy when your parent is the patient. In my 10 years of being a registered nurse, I have learned a lot, seen...
Cancer survivorship

Long-term cancer survivorship nurse practitioner care model promotes patient quality of life

It’s not uncommon for cancer patients to say they classify themselves as a cancer survivor by having lived at least 5 years past the...

Brushing up on mouth care for cancer patients with mucositis

Chemotherapy and radiation used to treat head and neck cancers, as well as high-dose chemo­therapy given to stem-cell transplant patients, can damage the mucosa...

Breast cancer care gets personal

Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss targeted therapy for...

When good people make hard choices…*

Leah Curtin discusses the difficulty of making choices in health care and includes a challenging situation she experienced as a student.

FDA approves drug for treating rare type of non-Hodgkin lymphoma

On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare...

FDA approves new indication for imaging agent

On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...

FDA approves Zykadia for NSCLC

On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer...

FDA approves Impavido to treat leishmaniasis

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.

FDA approves Imbruvica to treat chronic lymphocytic leukemia

On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have...

Study: Radiation therapy skin reactions may be preventable

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of...

Study: Melanoma increases among middle-aged adults

A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased nearly eightfold...